Induction of apoptosis in leukemic cells by the reversible microtubule-disrupting agent 2-methoxy-5-(2 ',3 ',4 '-trimethoxyphenyl)-2,4,6-cycloheptatrien-1-one: Protection by bcl-2 and bcl-x(L) and cell cycle arrest
C. Gajate et al., Induction of apoptosis in leukemic cells by the reversible microtubule-disrupting agent 2-methoxy-5-(2 ',3 ',4 '-trimethoxyphenyl)-2,4,6-cycloheptatrien-1-one: Protection by bcl-2 and bcl-x(L) and cell cycle arrest, CANCER RES, 60(10), 2000, pp. 2651-2659
We have found that the bicyclic colchicine analogue 2-methoxy-5-(2',3',4'-t
rimethoxyphenyl)-2,4,6-cycloheptatrien-1-one (MTC) induced a dose- and time
-dependent apoptotic response in human leukemic cells. MTC and colchicine r
apidly disrupted the microtubule integrity and arrested cells at the G(2)-M
phase before the onset of apoptosis, These responses were mediated by micr
otubule inhibition because 2-methoxy-5-[[3-(3,4,5-trimethoxyphenyl)propiony
l] one and lumicolchicine, inactive analogues of MTC and colchicine, respec
tively, were unable to promote microtubule disassembly, cell cycle arrest,
and apoptosis, Although 1 mu M R-ITC induced a complete microtubule disrupt
ion after 1 h of incubation in human leukemic HL-60 cells that led to an ac
cumulation of cells at the G(2)-M phase, MTC-induced apoptosis occurred aft
er 9 h of treatment. This indicates the existence of a rather long lag betw
een microtubule disruption and the onset of apoptosis. Unlike colchicine, t
he removal of MTC during this lag resulted in rapid microtubule repolymeriz
ation, followed by restoration of normal cell cycle and cell growth. MTC, b
ut not 2-methoxy-5-[[3-(3,4,5-trimethoxyphenyl) propionyl]amino]-2,4,6-cycl
oheptatrien-1-one induced c-jun expression as well as c-Jun NH2-terminal ki
nase and caspase activation, indicating that these signaling pathways are t
riggered by the specific action of MTC on microtubules, Caspase inhibition
prevented MTC-induced apoptosis. Overexpression of bcl-2 or bcl-x(L) by gen
e transfer in human erythroleukemic HEL cells abrogated MTC-induced apoptos
is, but cells remained arrested in G(2)-M, suggesting that bcl-2 and bcl-x(
L) block the signaling pathway between G(2)-M arrest and triggering of apop
tosis, MTC-treated bcl-2 and bcl-x(L)-transfected HEL cells recovered their
rapacity to proliferate after MTC removal. These results indicate that mic
rotubule inhibition induces G(2)-M arrest and apoptosis in leukemic cells,
showing a lag phase between G(2)-M arrest and the onset of apoptosis, regul
ated by bcl-2 and bcl-x(L) during which MTC displays a reversible action on
microtubule depolymerization and G(2)-M cell cycle arrest. Thus, MTC is a
potent apoptotic inducer on human leukemic cells and shows a remarkable rev
ersible action on microtubule network and cell cycle before commitment for
apoptosis is reached.